Shirley, NY, May 29, 2015 --(PR.com
)-- Creative Diagnostics is working with the antibody search engine CiteAb, the world's largest antibody search engine, with results ranked by citations, which provides an extensive list of antibodies with an advanced antibody search and browse interface that incorporates peer-reviewed publication information. The website now has a database of 2,149,734 antibodies, with 661,017 citations from 119 suppliers. And the number of suppliers and antibody products is still growing.
About Creative Diagnostics
Creative Diagnostics is a biotechnology company whose mission is to accelerate scientific discovery by developing and marketing unique products in the forefront of science. Creative Diagnostics provides primary antibodies, secondary antibodies, conjugated antibodies, antigens, hybridomas , diagnosis kits and devices, materials and reagents and ELISA development,antibody antigen services to the bioscience community. All of Creative Diagnostics' products are 100% guaranteed to work in the species and applications listed on the datasheet. By serving niche and emerging markets, Creative Diagnostics has formed and will continue to form increasing partnerships with leading researchers.
CiteAb Ltd is a biotechnology company located in Bath, England that offers an antibody search facility. CiteAb started life in 2013 as an academic project by Dr Andrew Chalmers, a senior lecturer at the University of Bath.The resource was established to help scientific researchers find suitable antibodies for their experiments.
CiteAb is the largest citation-ranked antibody search engine and provides a simple way to find antibodies that work. They use the number of citations as a transparent method to rank antibodies.
CiteAb offers a range of premium services, including provision of antibody market data, citation updates and an enhanced company profile on the website.
For more information on CiteAb, please visit www.citeab.com.